Richard Tom, MD
Obstetrics & Gynecology · Aurora, ILNPI 1952396517
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.9% of the total across 172 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 32 manufacturers reported payments, led by AbbVie at 24.1% of the total. Reporting peaked in 2022 at $850 and has fallen 84.1% since, to $135 in 2025.
Across 172 payments — averaging $18.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$771
- Bayer$342
- Hologic Sales And Service, LLC$244
- Myovant Sciences Inc.$174
- Merck$174
- Coopersurgical, Inc.$161
- plus $1K from 26 others
What the payments were for
- Food & beverage$3,13798%
- Education$672%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 31 | $771 |
| Bayer | 14 | $342 |
| Hologic Sales And Service, LLC | 14 | $244 |
| Myovant Sciences Inc. | 12 | $174 |
| Merck | 11 | $174 |
| Coopersurgical, Inc. | 11 | $161 |
| Aspira Women's Health Inc | 10 | $159 |
| Mylan Pharmaceuticals Inc. | 8 | $130 |
| Mayne Pharma Commercial LLC | 7 | $115 |
| Exeltis, USA Inc. | 7 | $108 |
| Organon | 5 | $103 |
| Therapeuticsmd, Inc. | 5 | $72 |
| Agile Therapeutics, Inc. | 4 | $70 |
| Pfizer | 4 | $62 |
| AMAG Pharmaceuticals, Inc. | 3 | $51 |
| Sumitomo Pharma America, Inc. | 3 | $48 |
| Astellas Pharma US Inc | 3 | $46 |
| Shield Therapeutics Inc | 2 | $43 |
| Vertex | 2 | $42 |
| Lupin Inc. | 3 | $42 |
| Amgen | 2 | $39 |
| Kerecis Limited | 1 | $26 |
| Biogen | 1 | $26 |
| Convatec Inc. | 1 | $26 |
| Mimedx Group, Inc. | 1 | $19 |
| Gynesonics, Inc. | 1 | $18 |
| Scynexis, Inc. | 1 | $18 |
| Pacira Pharmaceuticals Incorporated | 1 | $17 |
| Sanofi Pasteur Inc. | 1 | $17 |
| Dysis Medical, Inc. | 1 | $16 |
| Meditrina | 1 | $14 |
| Evofem Biosciences, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Orilissa$125
How this compares
$3,205 in reported general payments places this provider in the 85th percentile of 1,732 obstetrics & gynecology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Raloxifene Hcl | 17 | $416 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Aurora
- Dipti PatelAurora$12K
- Lee ShulmanChicago$559K
- Anne SchaibleOak Lawn$546K
- Christopher OlsonNaperville$530K
- Maria TamChicago$378K
- Charles MillerNaperville$317K
- Gregory UrsinoChicago$242K
- Buthaina JabirNaperville$199K
- Frank TugwellSterling$140K
- Ayman Al-HendyChicago$135K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.